
Gloryn Chia Lab
"Join the fight against cancer — pioneer the future of immunotherapy with us"

Principal Investigator
Assistant Professor Gloryn CHIA
Assistant Professor Gloryn Chia is a faculty member in the Department of Pharmacy at the National University of Singapore (NUS). She leads a research program focused on developing novel vaccines and stem cell therapies for the treatment of cancer and other human diseases. Her work particularly emphasizes personalized neoantigen vaccines, which are emerging as a promising class of immunotherapy. By harnessing new genomic technologies, her team aims to improve the efficacy of these vaccines and translate research findings into clinical practice for personalized cancer treatment.
Our Research

Neoantigen Therapy
Develop a pipeline to identify and validate neoantigens for personalized vaccines and TCR therapies, and discover new shared alternative neoantigens across cancer patients.

Immunotherapy
Identify and characterize immunotherapy targets, and develop therapeutic agents to enhance immune-mediated recognition and elimination of cancer cells

Tumor Biology
Elucidate mechanisms of immune dysfunction in drug-resistant cancers.
Team Members
Alumni
Acknowledgement
We gratefully acknowledge the generous support provided by our past and present funders







Upcoming Events
- So proud of Hongkai and Sharmistha for successfully completing your PhDs!Thu, 15 MaySingapore
- Congrats to Sharmistha on completing her PhD oral defense!Wed, 30 AprSingapore
- Group DinnerThu, 02 JanSingapore